Blackshear PJ - Search Results

1

Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin.

Cao H, Deterding LJ, Blackshear PJ. Cao H, et al. Among authors: blackshear pj. Expert Rev Proteomics. 2007 Dec;4(6):711-26. doi: 10.1586/14789450.4.6.711. Expert Rev Proteomics. 2007. PMID: 18067411 Free PMC article. Review.

2

Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway.

Carballo E, Cao H, Lai WS, Kennington EA, Campbell D, Blackshear PJ. Carballo E, et al. Among authors: blackshear pj. J Biol Chem. 2001 Nov 9;276(45):42580-7. doi: 10.1074/jbc.M104953200. Epub 2001 Sep 6. J Biol Chem. 2001. PMID: 11546803 Free PMC article.

3

Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.

Cao H, Dzineku F, Blackshear PJ. Cao H, et al. Among authors: blackshear pj. Arch Biochem Biophys. 2003 Apr 1;412(1):106-20. doi: 10.1016/s0003-9861(03)00012-2. Arch Biochem Biophys. 2003. PMID: 12646273 Free PMC article.

4

Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein.

Cao H, Tuttle JS, Blackshear PJ. Cao H, et al. Among authors: blackshear pj. J Biol Chem. 2004 May 14;279(20):21489-99. doi: 10.1074/jbc.M400900200. Epub 2004 Mar 9. J Biol Chem. 2004. PMID: 15010466 Free PMC article.

5

Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis.

Cao H, Deterding LJ, Venable JD, Kennington EA, Yates JR 3rd, Tomer KB, Blackshear PJ. Cao H, et al. Among authors: blackshear pj. Biochem J. 2006 Feb 15;394(Pt 1):285-97. doi: 10.1042/BJ20051316. Biochem J. 2006. PMID: 16262601 Free PMC article.

6

Diversity in penaeidin antimicrobial peptide form and function.

Cuthbertson BJ, Deterding LJ, Williams JG, Tomer KB, Etienne K, Blackshear PJ, Büllesbach EE, Gross PS. Cuthbertson BJ, et al. Among authors: blackshear pj. Dev Comp Immunol. 2008;32(3):167-81. doi: 10.1016/j.dci.2007.06.009. Epub 2007 Aug 3. Dev Comp Immunol. 2008. PMID: 17716729 Free PMC article. Review.

7

Identification of a major phosphopeptide in human tristetraprolin by phosphopeptide mapping and mass spectrometry.

Cao H, Deterding LJ, Blackshear PJ. Cao H, et al. Among authors: blackshear pj. PLoS One. 2014 Jul 10;9(7):e100977. doi: 10.1371/journal.pone.0100977. eCollection 2014. PLoS One. 2014. PMID: 25010646 Free PMC article.

8

RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of Au-rich MRNA-destabilizing motifs.

Brewer BY, Malicka J, Blackshear PJ, Wilson GM. Brewer BY, et al. Among authors: blackshear pj. J Biol Chem. 2004 Jul 2;279(27):27870-7. doi: 10.1074/jbc.M402551200. Epub 2004 Apr 26. J Biol Chem. 2004. PMID: 15117938 Free article.

9

Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.

Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR. Ogilvie RL, et al. Among authors: blackshear pj. J Immunol. 2005 Jan 15;174(2):953-61. doi: 10.4049/jimmunol.174.2.953. J Immunol. 2005. PMID: 15634918

10

Influence of nonameric AU-rich tristetraprolin-binding sites on mRNA deadenylation and turnover.

Lai WS, Carrick DM, Blackshear PJ. Lai WS, et al. Among authors: blackshear pj. J Biol Chem. 2005 Oct 7;280(40):34365-77. doi: 10.1074/jbc.M506757200. Epub 2005 Aug 1. J Biol Chem. 2005. PMID: 16061475 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters